Search clinical trials for: Placebo of Perindopril (P1)

Total 28736 results

Kyowa Kirin, Inc.

Completed

A Study of Istradefylline (KW-6002) for the Treatment of Parkinson's Disease in Patients Taking Levodopa

Parkinson's Disease

United States
Danish Headache Center

Completed

The Effect of Adenosine on Cranial Hemodynamic, Headache and Migraine Induction Properties.

Headache, Migraine

Denmark
Ain Shams University

Completed

Caffeine Intake Inrelation to Perioperative Analgesic Consumption

Analgesia | Caffeine

Egypt
The Hong Kong Polytechnic University

Completed

Exploring the Cortical Hemodynamic Variability of Four Weeks iTBS on a Healthy Participant: a Case Study

Healthy

Hong Kong
East Kent Hospitals University NHS Foundation Trust
KU Leuven; University of Kent; Sussex Community NHS Foundation Trust; l'Institut...

Completed

An Assistive Powered Wheelchair: Stage 2 Trial (EDUCAT)

Stroke | Multiple Sclerosis | Craniocerebral Trauma | Cystic Fibrosis | Guillain-Barre Syndrome | Motor Neurone Disease

United Kingdom
TRPHARM

Enrolling by invitation

Prevalence of Adenosine Deaminase (ADA) Enzyme Deficiency Disease in Adult Patients With Pulmonary Alveolar Proteinosis

Pulmonary Alveolar Proteinosis

Turkey
Gkouskou Kalliopi

Unknown

Associations Between Genetic Markers of Caffeine Metabolism, Appetite Hormones and Body Weight

Caffeine | Food Habits | Food Consumption and Appetite

Greece
The Guthrie Clinic

Withdrawn

Caffeinated Gum to Prevent Post-Operative Ileus: A Prospective, Randomized, Placebo-controlled Trial

C.Surgical Procedure; Digestive System

United States
David Grant U.S. Air Force Medical Center

Withdrawn

Synthetic and Natural Caffeine on Hemodynamic Parameters in Young, Healthy Volunteers

Cardiovascular Injury

United States
University Medical Center Goettingen

Completed

Cortical Excitability Changes on the Sensorimotor Cortex Induced by Caffeine Consumption: A TMS Study

Cortical Excitability | Brain Stimulation

Germany
Timothy M. Bateman, MD

Completed

Characterization of Myocardial Blood Flow Measurements Using Lexiscan®™ (Regadenoson) (Lexiscan®™) Rubidium-82 Myocardial Perfusion PET: A Temporal-Dependency Investigation

Myocardial Blood Flow Reserve

United States
Turku University Hospital
University of Bonn

Completed

Adenosine and A2A Receptors in Human Brown Adipose Tissue (AdenoBAT)

Obesity
Medical College of Wisconsin

Completed

Validation Durability Adenosine Effect in Verification Pulmonary Vein Isolation

Atrial Fibrillation

United States
Beth Israel Deaconess Medical Center

Completed

Caffeine in the Prevention of Post-operative Nausea and Vomiting

Postoperative Nausea and Vomiting

United States
Sunnybrook Health Sciences Centre
University Health Network, Toronto

Completed

Effect of an Automated Paging System on Response to Critical Laboratory Values

Drug Drug Interactions | Critical Laboratory Values | Drug Laboratory Interactions

Canada
David Garcia-Dorado
Hospital General Universitario Gregorio Marañon; Hospital Universitario Virgen... and other collaborators

Completed

Myocardial Protection With Adenosine During Primary Percutaneous Coronary Intervention in Pts With STEMI (PROMISE)

Acute Myocardial Infarction

Spain
Southern Illinois University Carbondale

Completed

Interaction of Caffeine and Hydration on Voice

Voice Disorders

United States
University of Florida

Withdrawn

The ARCTIC Trial: Aerosolized Inhaled Adenosine Treatment in Patients With Acute Respiratory Distress Syndrome (ARDS) Caused by COVID-19

Acute Respiratory Distress
Kyowa Kirin, Inc.

Completed

A Study of Istradefylline (KW-6002) in Treating Patients With Parkinson's Disease on Levodopa

Parkinson's Disease

United States
Kyowa Kirin Co., Ltd.
Kyowa Hakko Kirin UK, Ltd.

Completed

A Study of Istradefylline (KW-6002) for the Treatment of Parkinson's Disease

Parkinson's Disease

United Kingdom
Eskisehir Technical University

Completed

The Turkish Version Of The Brief-Caffeine Expectancy Questionnaire

Caffeine | Adaptation | Expectations | Language

Turkey
Georgetown University
Kyowa Kirin, Inc.

Active, not recruiting

Istradefylline Effect Protocol on Parkinson's Disease Tremor

Parkinson Disease | Tremor

United States
Universidad Francisco de Vitoria
Universidad de Granada; Universidad Rey Juan Carlos; Camilo Jose Cela University

Completed

Influence of the Time of Day in the Effect of Caffeine on Maximal Fat Oxidation During Exercise in Women (CIRCAF_WOM)

Dietary Supplement

Spain
TRPHARM

Enrolling by invitation

Investigation of ADA Enzyme Deficiency

Adenosine Deaminase Deficiency

Turkey
TRPHARM

Enrolling by invitation

Evaluation of Adenosine Deaminase (ADA) Enzyme Deficiency in Patients With Lymphopenia and/or Elevated Immunoglobulin E

Adenosine Deaminase Deficiency

Turkey
PepsiCo Global R&D

Completed

Pilot Study Characterizing the Pharmacokinetic Profile of a Novel Encapsulated Caffeine Beverage in the Fed and Fasted States

Pharmacokinetics

United States
Hacettepe University

Unknown

Direct Effect of Caffeine on Diaphragmatic Muscles

Caffeine

Turkey
Assistance Publique - Hôpitaux de Paris

Unknown

Caffeine Efficacy in ADCY5-related Dyskinesia (ADCY5-CAF)

ADCY5-related Dyskinesia
Texas Woman's University

Completed

Increased Static Postural Sway After Energy Drink Consumption

Disorder

Puerto Rico
Paul Kim
Astellas Pharma Inc

Completed

Stress Cardiac MRI for Evaluation of Nonspecific Allograft Dysfunction

Acute Graft Rejection | Heart Transplant | Chronic Graft Rejection

United States
Yong Seog Oh

Completed

Adenosine Effect on Persistent Pulmonary Vein Isolation Line Evaluation (APPLE Trial) (APPLE)

Atrial Fibrillation | Persistent Common Pulmonary Vein

Korea, Republic of
M.D. Anderson Cancer Center
National Cancer Institute (NCI); FDA Office of Orphan Products Development

Completed

8-Chloro-Adenosine in Chronic Lymphocytic Leukemia

Leukemia | Chronic Lymphocytic Leukemia

United States
Mansoura University Children Hospital

Completed

High Versus Low Dose of Caffeine for Apnea of Prematurity

Apnea | Preterm Infants

Egypt
Johns Hopkins University
National Institute on Drug Abuse (NIDA)

Completed

Assessment and Treatment of Caffeine Dependence

Self-identified Problematic Caffeine Use | DSM-IV Substance Dependence as Applied to Caffeine

United States
University Hospital, Basel, Switzerland

Completed

Chronic Hepatitis C Non-Responder Study With AdoMet and Betaine

Hepatitis C

Switzerland
Iovate Health Sciences International Inc
Citruslabs

Completed

Effect of Different Dosages of Paraxanthine, the Major Caffeine Metabolite, on Energy and Focus

Caffeine Withdrawal | Energy | Focus

United States
University of Aberdeen
Lipton Teas and Infusions

Recruiting

Understanding the Effects of Daily Tea Consumption on Attention, Sleep, and Mood, in Healthy Adults (Reactivi-Tea)

The Focus of the Study is Healthy Volunteers

United Kingdom
GlaxoSmithKline

Completed

A Study to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of an Intravenous Infusion of GW328267X in Healthy Volunteers

Lung Injury, Acute

United Kingdom
Kyowa Kirin Co., Ltd.
Kyowa Hakko Kirin Pharma, Inc.

Completed

A Study to Evaluate Abuse Potential of Istradefylline

Drug Abuse

United States
Wake Forest University Health Sciences
National Institute of Neurological Disorders and Stroke (NINDS)

Completed

Clonidine Versus Adenosine to Treat Neuropathic Pain

Pain

United States
ProMedica Health System

Completed

Efficacy of Energy Shots and Caffeine for Energy and Wakefulness Levels

Focus: to Compare a Commercially Available Energy Drink, B Vitamins, Caffeine Alone, and Placebo for Effectiveness on Perceived Energy Level and Wakefulness

United States
Technical University of Munich

Completed

Acetylcysteine, Theophylline, and a Combination of Both in the Prophylaxis of Contrast-Induced Nephropathy (ATHENS)

Kidney Diseases | Renal Failure | Adverse Effects | Contrast Induced Nephropathy

Germany
Kyowa Kirin, Inc.
Kyowa Kirin Co., Ltd.

Terminated

An Extension of Istradefylline in North American Parkinson's Disease Patients Who Have Completed Study 6002-INT-001

Parkinson's Disease

United States
Kyowa Kirin, Inc.

Completed

12-Week, Double-Blind, Placebo-Controlled, Randomized Study of the Efficacy of 40 mg/Day KW-6002 in Parkinson's Disease Patients on Levodopa/Carbidopa

Parkinson's Disease

United States
Kyowa Kirin, Inc.

Completed

12-Week, Double-Blind, Placebo-Controlled Study of 20 and 60 mg/Day Istradefylline in Parkinson's Disease Patients on Levodopa/Carbodopa

Parkinson's Disease

United States
Kyowa Kirin, Inc.
Kyowa Hakko Kirin UK, Ltd.

Completed

An Extension of Istradefylline in Parkinson's Disease Patients Who Have Completed Studies 6002-EU-007, 6002-US-013 or 6002-US-018

Parkinson's Disease

United States
Istituto Auxologico Italiano
Antonella Groppelli

Completed

Rapid Measurement of Adenosine in Syncope Patients (BlotSpot)

Syncope

Italy
NeuroCatch Inc.

Completed

Sleep Deprivation Study

Cognitive Change | Sleep Deprivation | Caffeine

Canada
Morten Hostrup, PhD

Active, not recruiting

Effects of Combinations of Performance-enhancing Supplements on Exercise Performance

Healthy

Denmark
Pfizer

Completed

Estimation of the Effect of Multiple Dose Ritlecitinib (PF-06651600) on the Pharmacokinetics of a Single Dose of Caffeine in Healthy Participants

Healthy Participants

United States

Search clinical trials for: Placebo of Perindopril (P1)

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Saudi Arabia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations